Search research articles
Contact Us
Filters
Showing results (41-50 of 53) with videos related to
Page
of 6
Sort By:
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Navigating parasite antigen genetic diversity in the design of <i>Plasmodium vivax</i> serological exposure markers for malaria
Paolo Bareng, Kenneth W Wu, Eizo Takashima, et al.
Nature
|
December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex
Wilson Wong, Rick Huang, Sebastien Menant, et al.
The Lancet. Microbe
|
May 19, 2026
Assessing the effect of parasite antigen genetic diversity on performance of Plasmodium vivax serological exposure markers for malaria: a multicentre observational diagnostic accuracy study
Alison Paolo N Bareng, Kenneth W Wu, Eizo Takashima, et al.
Cell Reports. Medicine
|
June 22, 2022
Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
Rhea J Longley, Matthew J Grigg, Kael Schoffer, et al.
Elife
|
September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine development
Camila Tenorio França, Michael T White, Wen-Qiang He, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development
Jack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Frontiers in Cellular and Infection Microbiology
|
January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
Julie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
JCI Insight
|
June 15, 2021
High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria
Lisa J Ioannidis, Halina M Pietrzak, Ann Ly, et al.
Vaccine
|
September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers
Michele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Molecular Systems Biology
|
April 27, 2022
Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria
Stephanie I Studniberg, Lisa J Ioannidis, Retno A S Utami, et al.
Page
of 6
Search research articles
Search
Showing results (41-50 of 53) with videos related to
Sort By:
Page
of 6
Biorxiv : the Preprint Server for Biology
|
July 17, 2025
Navigating parasite antigen genetic diversity in the design of <i>Plasmodium vivax</i> serological exposure markers for malaria
Paolo Bareng, Kenneth W Wu, Eizo Takashima, et al.
Nature
|
December 14, 2018
Structure of Plasmodium falciparum Rh5-CyRPA-Ripr invasion complex
Wilson Wong, Rick Huang, Sebastien Menant, et al.
The Lancet. Microbe
|
May 19, 2026
Assessing the effect of parasite antigen genetic diversity on performance of Plasmodium vivax serological exposure markers for malaria: a multicentre observational diagnostic accuracy study
Alison Paolo N Bareng, Kenneth W Wu, Eizo Takashima, et al.
Cell Reports. Medicine
|
June 22, 2022
Plasmodium vivax malaria serological exposure markers: Assessing the degree and implications of cross-reactivity with P. knowlesi
Rhea J Longley, Matthew J Grigg, Kael Schoffer, et al.
Elife
|
September 27, 2017
Identification of highly-protective combinations of <i>Plasmodium vivax</i> recombinant proteins for vaccine development
Camila Tenorio França, Michael T White, Wen-Qiang He, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 19, 2013
Identification and prioritization of merozoite antigens as targets of protective human immunity to Plasmodium falciparum malaria for vaccine and biomarker development
Jack S Richards, Thangavelu U Arumugam, Linda Reiling, et al.
Frontiers in Cellular and Infection Microbiology
|
January 6, 2023
RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting
Julie Healer, Jennifer K Thompson, Karen L Mackwell, et al.
JCI Insight
|
June 15, 2021
High-dimensional mass cytometry identifies T cell and B cell signatures predicting reduced risk of Plasmodium vivax malaria
Lisa J Ioannidis, Halina M Pietrzak, Ann Ly, et al.
Vaccine
|
September 14, 2013
First-in-human evaluation of genetically attenuated Plasmodium falciparum sporozoites administered by bite of Anopheles mosquitoes to adult volunteers
Michele Spring, Jittawadee Murphy, Robin Nielsen, et al.
Molecular Systems Biology
|
April 27, 2022
Molecular profiling reveals features of clinical immunity and immunosuppression in asymptomatic P. falciparum malaria
Stephanie I Studniberg, Lisa J Ioannidis, Retno A S Utami, et al.
Page
of 6